Ten global health organisations today launched “Fight the Fakes,” a global campaign against “fake” medicines, aimed at raising awareness about medicines – brand or generic – that are not what they claim to be. Meanwhile, a Swiss pharmaceutical company official was named head of investigations at a top international public health organisation.

One of the more promising TB drugs to emerge recently is extremely expensive. The drug is called linezolid and it is patented by Pfizer. One pill costs R676 per day.

Honey bees, known for their extraordinary sense of smell, can be trained to sniff out cancer, TB and diabetes in humans, scientists have found.

03 November 2013 - Paris - The Stop TB Partnership, KELIN, UNAIDS and The Global Fund to Fight AIDS, Tuberculosis & Malaria partnered to run a symposium on the connections between HIV, tuberculosis (TB), human rights and the law at the 44th Union World Conference on Lung Health, in Paris, France.

25 November 2013 – Geneva – The Global Fund Fourth Voluntary Replenishment Conference, No Time to Lose: Sharing the Responsibility to Save Lives, will be hosted by the United States government in Washington D.C. from 2-3 December.

Reach the three million
A TB test, treatment and cure for all

Eisai Co., Ltd. (Headquarters: Tokyo, President & CEO: Haruo Naito, “Eisai”) announced today that it has become a signatory to the Tuberculosis Drug Accelerator (TBDA) partnership, a groundbreaking initiative that aims to speed up the discovery of essential new treatments for tuberculosis (TB).

Second in a series of symposia calling for Zero TB Deaths, New Infections, and Suffering.

Cape Town - Khayelitsha’s Zoliswa Mkiva, 32, is the third patient in the township to be cured of extreme drug resistant tuberculosis (XDR TB).

October 2-3, 2013
Marriott Renaissance Hotel, Washington DC